Results of a Pulmonologist Survey Regarding Knowledge and Practices With Inhalation Devices for COPD

References

1. 1.↵
   1. Celli BR,
   2. MacNee W

   ; ATS/ERS Task Force. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004 23(6):932–946.

   OpenUrlFREE Full Text
2. 2.↵
   From the Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2017. http://goldcopd.org>. Accessed May 1, 2017.
3. 3.↵
   1. Dolovich MB,
   2. Dhand R

   . Aerosol drug delivery: developments in device design and clinical use. Lancet 2011;377(9770):1032–1045.

   OpenUrlCrossRefPubMed
4. 4.↵
   1. Darquenne C

   . Aerosol deposition in health and disease. J Aerosol Med Pulm Drug Deliv 2012;25(3):140–147.

   OpenUrlCrossRefPubMed
5. 5.↵
   1. Pirozynski M,
   2. Sosnowski TR

   . Inhalation devices: from basic science to practical use, innovative vs generic products. Expert Opin Drug Deliv 2016;13(11):1559–1571.

   OpenUrl
6. 6.↵
   1. Boe J,
   2. Dennis JH,
   3. O'Driscoll BR,
   4. Bauer TT,
   5. Carone M,
   6. Dautzenberg B,
   7. et al

   ; European Respiratory Society Task Force on the use of nebulizers. European Respiratory Society Guidelines on the use of nebulizers. Eur Respir J 2001;18(1):228–242.

   OpenUrlFREE Full Text
7. 7.↵
   1. O'Donohue WJ Jr.

   . Guidelines for the use of nebulizers in the home and at domiciliary sites. Report of a consensus conference. National Association for Medical Direction of Respir Care (NAMDRC) Consensus Group. Chest 1996;109(3):814–820.

   OpenUrlCrossRefPubMed
8. 8.↵
   1. Collins FS,
   2. Varmus H

   . A new initiative on precision medicine. N Engl J Med 2015;372(9):793–795.

   OpenUrlCrossRefPubMedWeb of Science
9. 9.↵
   1. Lavorini F,
   2. Fontana GA,
   3. Usmani OS

   . New inhaler devices—the good, the bad and the ugly. Respiration 2014;88(1):3–15.

   OpenUrl
10. 10.↵
    1. Rau JL

    . Practical problems with aerosol therapy in COPD. Respir Care 2006;51(2):158–172.

    OpenUrlAbstract/FREE Full Text
11. 11.↵
    Code of Federal Regulations, Title 45, Part 46. Protection of human subject. https://www.hhs.gov/ohrp/regulations-and-policy/regulations/45-cfr-46/index.html. Accessed December 1, 2015.
12. 12.↵
    1. Eysenbach G

    . Improving the quality of web surveys: the checklist for reporting results of internet e-surveys (CHERRIES). J Med Internet Res 2004;6(3):e34.

    OpenUrlCrossRefPubMed
13. 13.↵
    1. Bestall JC,
    2. Paul EA,
    3. Garrod R,
    4. Garnham R,
    5. Jones PW,
    6. Wedzicha JA

    . Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 1999;54(7):581–586.

    OpenUrlAbstract/FREE Full Text
14. 14.↵
    1. Dolovich MB,
    2. Ahrens RC,
    3. Hess DR,
    4. Anderson P,
    5. Dhand R,
    6. Rau JL,
    7. et al

    ; American College of Chest Physicians; American College of Asthma, Allergy, and Immunology. Device selection and outcomes of aerosol therapy: evidence-based guidelines. Chest 2005;127(1):335–371.

    OpenUrlCrossRefPubMedWeb of Science
15. 15.↵
    1. Guidry GG,
    2. Brown WD,
    3. Stogner SW,
    4. George RB

    . Incorrect use of metered dose inhalers by medical personnel. Chest 1992;101(1):31–33.

    OpenUrlCrossRefPubMedWeb of Science
16. 16.
    1. Interiano B,
    2. Guntupalli KK

    . Metered-dose inhalers. Do health care providers know what to teach? Arch Intern Med 1993;153(1):81–85.

    OpenUrlCrossRefPubMedWeb of Science
17. 17.
    1. Hanania NA,
    2. Wittman R,
    3. Kesten S,
    4. Chapman KR

    . Medical personnel's knowledge of and ability to use inhaling deices. Metered-dose inhalers, spacing chambers, and breath-actuated dry powder inhalers. Chest 1994;105(1):111–116.

    OpenUrlCrossRefPubMedWeb of Science
18. 18.↵
    1. Alismail A,
    2. Song CA,
    3. Terry MH,
    4. Daher N,
    5. Almutairi WA,
    6. Lo T

    . Diverse inhaler devices: a big challenge for health-care professionals. Respir Care 2016;61(5):593–599.

    OpenUrlAbstract/FREE Full Text
19. 19.↵
    1. de Monte M,
    2. Scruignec J,
    3. Dubus JC,
    4. Chaumuzeau JP,
    5. Dautzenberg B,
    6. Dessanges JF,
    7. et al

    . GAT. N.U.A.G.ES: A survey of nebulisation practice in France with regard to ERS guidelines. Respir Med 2007;101(12):2561–2565.

    OpenUrlPubMed
20. 20.↵
    1. Melani AS,
    2. Canessa P,
    3. Coloretti I,
    4. DeAngelis G,
    5. DeTullio R,
    6. DelDonno M,
    7. et al

    .; Educational Study Group of the Italian Association of Hospital Pulmonologists (AIPO). Inhaler mishandling is very common in patients with chronic airflow obstruction and long-term home nebuliser use. Respir Med 2012;106:668–676.

    OpenUrlCrossRefPubMed
21. 21.↵
    1. Melani AS,
    2. Bonavia M,
    3. Cilenti V,
    4. Cinti C,
    5. Lodi M,
    6. Martucci P,
    7. et al

    .; Gruppo Educazionale Associazione Italiana Pneumologi Ospedalieri. Inhaler mishandling remains common in real life and is associated with reduced disease control. Respir Med 2011;105(6):930–938.

    OpenUrlCrossRefPubMed
22. 22.↵
    1. Sanchis J,
    2. Gich I,
    3. Pedersen S

    ; on behalf of the Aerosol Drug Management Improvement Team (ADMIT). Systematic review of errors in inhaler use. Has patient technique improved over time? Chest 2016;150(2):394–406.

    OpenUrlCrossRefPubMed
23. 23.↵
    1. Dhand R,
    2. Dolovich M,
    3. Chipps B,
    4. Myers TR,
    5. Restrepo R,
    6. Farrar JR

    . The role of nebulized therapy in the management of COPD: evidence and recommendations. COPD 2012;9(1):58–72.

    OpenUrl
24. 24.↵
    1. Press VG,
    2. Arora VM,
    3. Shah LM,
    4. Lewis SL,
    5. Ivy K,
    6. Charbeneau J,
    7. et al

    . Misuse of respiratory inhalers in hospitalized patients with asthma or COPD. J Gen Intern Med 2011;26(6):635–642.

    OpenUrlCrossRefPubMed
25. 25.↵
    1. Dhand R,
    2. Mahler DA,
    3. Carlin B,
    4. Hanania N,
    5. Ohar J,
    6. Pinto-Plata V,
    7. et al

    . Results of a patient survey regarding COPD knowledge, treatment experiences, and practices with inhalation devices. Respir Care 2018 Mar 20. [Epub ahead of print].
26. 26.↵
    1. Souza ML,
    2. Meneghini AC,
    3. Ferraz E,
    4. Vianna EO,
    5. Borges MC

    . Knowledge of and technique for using inhalation devices among asthma patients and COPD patients. J Bras Pneumol 2009;35(9):824–831.

    OpenUrlCrossRefPubMed
27. 27.
    1. Myers TR

    . The science guiding selection of an aerosol delivery device. Respir Care 2013;58(11):1963–1973.

    OpenUrlAbstract/FREE Full Text
28. 28.↵
    1. Goodman DE,
    2. Israel E,
    3. Rosenberg M,
    4. Johnston R,
    5. Weiss ST,
    6. Drazen JM

    . The influence of age, diagnosis, and gender on proper use of metered-dose inhalers. Am J Respir Crit Care Med 1994;150(5 Pt 1):1256–1261.

    OpenUrlCrossRefPubMedWeb of Science
29. 29.↵
    COPD e-Newsletter. Available at http://www.nhlbi.nih.gov/health/public/lung/copd/. Accessed August 2, 2016.
30. 30.↵
    1. Kesser KC,
    2. Geller DE

    . New aerosol delivery devices for cystic fibrosis. Respir Care 2009;54(6):754–767; discussion 767-768.

    OpenUrlAbstract/FREE Full Text
31. 31.↵
    1. Agent P,
    2. Parrott H

    . Inhaled therapy in cystic fibrosis: agents, devices and regimens. Breathe (Sheff) 2015;11(2):111–118.

    OpenUrl
32. 32.↵
    1. AZ C,
    2. Ceylan E,
    3. Pekcan S,
    4. Yılmaz Ö,
    5. Öztürk S,
    6. et al

    . The knowledge and considerations of the physicians regarding the inhaler devices in asthma and COPD: the INTEDA-1 study. Tuberk Toraks 2013;61(3):183–192.

    OpenUrl
33. 33.↵
    1. Melani AS,
    2. Sestini P,
    3. Aiolfi S,
    4. Barbato N,
    5. Canessa P,
    6. De Angelis G,
    7. et al

    .; Associazone Italiana Pneumologi Ospedalieri (AIPO) Educational Group. GENebu Project: home nebulizer use and maintenance in Italy. Eur Respir J 2001;18(5):758–763.

    OpenUrlAbstract/FREE Full Text
34. 34.↵
    1. Cobben NA,
    2. Drent M,
    3. Jonkers M,
    4. Wouters EF,
    5. Vaneechoutte M,
    6. Stobberingh EE

    . Outbreak of severe Pseudomonas aeruginosa respiratory infections due to contaminated nebulizers. J Hosp Infect 1996;33(1):63–70.

    OpenUrlCrossRefPubMedWeb of Science
35. 35.↵
    1. O'Malley CA

    . Device cleaning and infection control in aerosol therapy. Respir Care 2015;60(6):917–927; discussion 928-930.

    OpenUrlAbstract/FREE Full Text
36. 36.↵
    1. Fromer L,
    2. Goodwin E,
    3. Walsh J

    . Customizing inhaled therapy to meet the needs of COPD patients. Postgrad Med 2010;122(2):83–93.

    OpenUrlCrossRefPubMed
37. 37.↵
    1. Sharafkhaneh A,
    2. Wolf RA,
    3. Goodnight S,
    4. Hanania NA,
    5. Make BJ,
    6. Tashkin DP

    . Perceptions and attitudes toward the use of nebulized therapy for COPD: patient and caregiver perspectives. COPD 2013;10(4):482–492.

    OpenUrl
38. 38.↵
    1. Roggeri A,
    2. Micheletto C,
    3. Paola Roggeri D

    . Inhalation errors due to device switch in patients with chronic obstructive pulmonary disease and asthma: critical health and economic issues. and economic issues. Int J Chronic Obstruct Pulmon Dis 2016;11:597–602.

    OpenUrl